| Wendy K Ottenbacher, MD | |
|
701 N Clayton St, Wilmington, DE 19805-3165 | |
| (302) 421-4333 | |
| Not Available |
| Full Name | Wendy K Ottenbacher |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 701 N Clayton St, Wilmington, Delaware |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114907367 | NPI | - | NPPES |
| P00430507 | Other | MD | RAILROAD |
| 1114907367 | Medicaid | DE | |
| 129151000 | Medicaid | MD | |
| 413046400 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D0065609 (Maryland) | Secondary |
| 207P00000X | Emergency Medicine | L8872 (Texas) | Secondary |
| 207P00000X | Emergency Medicine | C1-008290 (Delaware) | Primary |
| Entity Name | Emergency Physician Associates Of Delaware Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679514467 PECOS PAC ID: 5294716601 Enrollment ID: O20040731000066 |
News Archive
Long-time funding for work at the Penn Center for Musculoskeletal Disorders has been renewed for another five years by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health.
Birth defects characterized by malformation of the limbs are relatively common.
Doctors need better ways to detect and monitor heart disease, the leading cause of death in industrialized countries. A team led by Massachusetts General Hospital researchers with support from the National Institute of Biomedical Imaging and Bioengineering has developed an improved optical imaging technique that found differences between potentially life-threatening coronary plaques and those posing less imminent danger for patients with coronary artery disease.
Stereotaxis, Inc. today announces the introduction of its new Vdrive™, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology (EP) procedures. The company is planning to preview the Vdrive at the HRS meeting this week, and will be commercially available when regulatory processes are complete.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy K Ottenbacher, MD 701 N Clayton St, Wilmington, DE 19805-3165 Ph: () - | Wendy K Ottenbacher, MD 701 N Clayton St, Wilmington, DE 19805-3165 Ph: (302) 421-4333 |
News Archive
Long-time funding for work at the Penn Center for Musculoskeletal Disorders has been renewed for another five years by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health.
Birth defects characterized by malformation of the limbs are relatively common.
Doctors need better ways to detect and monitor heart disease, the leading cause of death in industrialized countries. A team led by Massachusetts General Hospital researchers with support from the National Institute of Biomedical Imaging and Bioengineering has developed an improved optical imaging technique that found differences between potentially life-threatening coronary plaques and those posing less imminent danger for patients with coronary artery disease.
Stereotaxis, Inc. today announces the introduction of its new Vdrive™, an expansion of its Magnetic Navigation platform that facilitates remote manipulation of diagnostic devices used during electrophysiology (EP) procedures. The company is planning to preview the Vdrive at the HRS meeting this week, and will be commercially available when regulatory processes are complete.
Tolerx, Inc., today announced the completion of patient enrollment in its Phase 3 clinical study DEFEND-1, which is evaluating the safety and efficacy of otelixizumab, a targeted T cell immunomodulator, in patients with new-onset autoimmune type 1 diabetes.
› Verified 7 days ago
Dr. Alexandra A. Taylor, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Jonathan Beri, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd Ste 2b80, Wilmington, DE 19803 Phone: 302-651-5874 Fax: 302-651-5954 | |
John V. Fenice, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2601 Annand Dr, Suite 4, Wilmington, DE 19808 Phone: 302-998-3334 Fax: 302-998-8985 | |
Dr. Susanne I. Kost, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 | |
Monique A Devens, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-5860 Fax: 302-651-4227 | |
Brent R. King, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1600 Rockland Rd, Wilmington, DE 19803 Phone: 302-651-5860 Fax: 302-651-4227 | |
Dr. Steven M. Selbst, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803 Phone: 302-651-4000 Fax: 302-651-4945 |